Announcing

a Special Anniversary Rate for tct 2018!

For practicing physicians, academic researchers, and allied health professionals

30 Years of Groundbreaking Science, Training, and Innovation

Embargo Policy for TCT 2018

Please note that press conference presentations of late-breaking trials and late-breaking clinical science at TCT are held prior to the Main Arena presentations as a courtesy to the media. Embargoes do not lift until the start of each individual Main Arena presentation, as listed in the TCT agenda. All embargo times are listed in Pacific Time (PT). Please note this schedule is subject to change.

Saturday, September 22, 2018
7:30 AM - 9:00 AM

Moderator: Roxana Mehran, MD
Co-Moderator: Michael R. Jaff, DO

7:30 AM
TALENT: A Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Coronary Drug-Eluting Stent in an All-Comers Patient Population
Patrick W. Serruys, MD, PhD

Embargo Lift Time: 12:46 PM PT

7:45 AM
BIONYX: A Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Coronary Drug-Eluting Stent in an All-Comers Patient Population
Clemens von Birgelen, MD, PhD

Embargo Lift Time: 10:41 AM PT

8:00 AM
ReCre8: A Randomized Trial Evaluating a Polymer-Free Coronary Drug-Eluting Stent in an All-Comers Patient Population
Pieter R. Stella, MD, PhD

Embargo Lift Time: 11:01 AM PT

8:15 AM
LEADERS FREE II: Evaluation of a Polymer-Free Coronary Drug-Eluting Stent in High Bleeding-Risk Patients With One-Month Dual Antiplatelet Therapy
Mitchell W. Krucoff, MD

Embargo Lift Time: 12:06 PM PT

8:30 AM
IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions
William A. Gray, MD

Embargo Lift Time: 10:21 AM PT

8:45 AM
SORT OUT IX: A Randomized Trial Comparing a Polymer-Free Coronary Drug-Eluting Stent With an Ultra-Thin Strut Bioresorbable Polymer-Based Drug-Eluting Stent in an All-Comers Patient Population
Lisette Okkels Jensen, MD, DMSci, PhD

Embargo Lift Time: 12:26 PM PT

Sunday, September 23, 2018
7:30 AM - 9:15 AM

Moderator: Ori Ben-Yehuda, MD

7:30 AM
COAPT: A Randomized Trial of Transcatheter Mitral Valve Leaflet Approximation in Patients With Heart Failure and Secondary Mitral Regurgitation
Gregg W. Stone, MD

Embargo Lift Time: 10:20 AM PT

7:45 AM
Prosthesis-Patient Mismatch: Incidence, Predictors, and Outcome of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement
Howard C. Herrmann, MD

Embargo Lift Time: 12:35 PM PT

8:00 AM
SOLVE-TAVI: A 2x2 Randomized Trial of Self-Expandable vs Balloon-Expandable Valves and General vs Local Anesthesia in Patients Undergoing Transcatheter Aortic Valve Implantation
Holger Thiele, MD

Embargo Lift Time: 11:00 AM PT

8:15 AM
PADN-5: A Randomized Trial of Pulmonary Artery Denervation in Patients With Combined Pre- and Postcapillary Pulmonary Hypertension
Shao-Liang Chen, MD

Embargo Lift Time: 12:05 PM PT

8:30 AM
PARTNER VALVE-IN-VALVE: Late Follow-up After Treatment of Failing Surgical Aortic Bioprosthetic Valves With a Balloon-Expandable Transcatheter Heart Valve
John G. Webb, MD

Embargo Lift Time: 12:20 PM PT

8:45 AM
REDUCE-FMR: A Sham-Controlled Randomized Trial of Transcatheter Mitral Valve Indirect Annuloplasty in Patients With Heart Failure and Secondary Mitral Regurgitation
Horst Sievert, MD

Embargo Lift Time: 10:45 AM PT

9:00 AM
TRIVALVE: Evaluation of Edge-to-Edge Valve Repair for Symptomatic Tricuspid Regurgitation
Jörg Hausleiter, MD

Embargo Lift Time: 12:50 PM PT

Monday, September 24, 2018
7:30 AM - 9:15 AM

Moderator: Juan F. Granada, MD
Co-Moderator: C. Michael Gibson, MS, MD

7:30 AM
FAST-FFR: Accuracy of Fractional Flow Reserve Derived From Coronary Angiography
William F. Fearon, MD

Embargo Lift Time: 12:05 PM PT

7:45 AM
LRP: Assessment of Coronary Near-Infrared Spectroscopy Imaging to Detect Vulnerable Plaques and Vulnerable Patients
Ron Waksman, MD

Embargo Lift Time: 10:40 AM PT

8:00 AM
OAC ALONE: A Randomized Trial of Oral Anticoagulation With vs Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation Beyond One Year After Drug-Eluting Stent Implantation
Yukiko Nakano, MD

Embargo Lift Time: 11:00 AM PT

8:15 AM
ULTIMATE: A Randomized Trial of Intravascular Ultrasound Guidance of Coronary Drug-Eluting Stent Implantation in an All-Comers Patient Population
Junjie Zhang, MD

Embargo Lift Time: 10:20 AM PT

8:30 AM
SYNTAXES: Ten-Year Follow-up From a Randomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main and Triple Vessel Disease
Daniel J.F.M. Thuijs, MSc, MD

Embargo Lift Time: 12:35 PM PT

8:45 AM
MAIN-COMPARE: Ten-Year Follow-up From a Nonrandomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main Disease
Seung-Jung Park, MD, PhD

Embargo Lift Time: 12:50 PM PT

9:00 AM
PREPARE-CALC: A Randomized Trial of High-speed Rotational Atherectomy Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions
Gert Richardt, MD, PhD

Embargo Lift Time: 12:20 PM PT

Tuesday, September 25, 2018
7:30 AM – 9:15 AM

Moderator: Ajay J. Kirtane, MD, SM

7:30 AM
ABSORB IV: A Blinded Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in an Expanded Patient Population Using Optimized Technique
Gregg W. Stone, MD

Embargo Lift Time: 10:00 AM PT

7:45 AM
COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions
Pieter C. Smits, MD, PhD

Embargo Lift Time: 10:20 AM PT

8:00 AM
RADIOSOUND-HTN: A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension Philipp Lurz, MD, PhD

Embargo Lift Time: 10:40 AM PT

8:15 AM
CorMicA: A Randomized Trial of Invasive Coronary Function Testing in Patients With Angina and Nonobstructive Coronary Artery Disease
Tom J. Ford, MBChB

Embargo Lift Time: 11:00 AM PT

8:30 AM
RESET: Seven-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents in Patients With Coronary Artery Disease
Hiroki Shiomi, MD, PhD

Embargo Lift Time: 11:15 AM PT

8:45 AM
NEOPRO: Nonrandomized Comparison of Two Transcatheter Heart Valve in Patients With Severe Aortic Stenosis
Azeem Latib, MB, BCh

Embargo Lift Time: 11:30 AM PT

9:00 AM
PORTICO I: One-Year Outcomes With a Self-Expanding, Repositionable Transcatheter Heart Valve in Patients With Severe Aortic Stenosis
Lars Søndergaard, MD, DMSc

Embargo Lift Time: 11:45 AM PT